NO902921L - Antibiotisk middel. - Google Patents

Antibiotisk middel.

Info

Publication number
NO902921L
NO902921L NO90902921A NO902921A NO902921L NO 902921 L NO902921 L NO 902921L NO 90902921 A NO90902921 A NO 90902921A NO 902921 A NO902921 A NO 902921A NO 902921 L NO902921 L NO 902921L
Authority
NO
Norway
Prior art keywords
antibiotic agent
cultivation
isolation
production
activity against
Prior art date
Application number
NO90902921A
Other languages
English (en)
Other versions
NO178343B (no
NO902921D0 (no
NO178343C (no
Inventor
Robert E Schwartz
Raymond F White
Jerrold M Liesch
Otto D Hensens
Henry Joshua
Dennis M Schmatz
Robert A Giacobbe
Jan S Tkacz
Prakash S Masurekar
Louis Kaplan
Margaret S Sosa
Jimmy M Fountoulakis
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/492,026 external-priority patent/US5021341A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO902921D0 publication Critical patent/NO902921D0/no
Publication of NO902921L publication Critical patent/NO902921L/no
Publication of NO178343B publication Critical patent/NO178343B/no
Publication of NO178343C publication Critical patent/NO178343C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO902921A 1989-06-30 1990-06-29 Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B NO178343C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37441689A 1989-06-30 1989-06-30
US49202490A 1990-03-12 1990-03-12
US49202590A 1990-03-12 1990-03-12
US07/492,026 US5021341A (en) 1990-03-12 1990-03-12 Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol

Publications (4)

Publication Number Publication Date
NO902921D0 NO902921D0 (no) 1990-06-29
NO902921L true NO902921L (no) 1991-01-02
NO178343B NO178343B (no) 1995-11-27
NO178343C NO178343C (no) 1996-03-06

Family

ID=27503114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902921A NO178343C (no) 1989-06-30 1990-06-29 Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B

Country Status (16)

Country Link
EP (1) EP0405997B1 (no)
JP (1) JPH0764873B2 (no)
KR (1) KR0145693B1 (no)
AT (1) ATE109160T1 (no)
AU (1) AU639698B2 (no)
CA (1) CA2020062C (no)
CY (1) CY1962A (no)
DE (1) DE69011006T2 (no)
DK (1) DK0405997T3 (no)
ES (1) ES2057413T3 (no)
FI (1) FI93647C (no)
HK (1) HK209496A (no)
IL (1) IL94862A (no)
NO (1) NO178343C (no)
NZ (1) NZ234225A (no)
PT (1) PT94555B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5310873A (en) * 1990-03-12 1994-05-10 Merck & Co., Inc. Cyclohexapeptide compound
US5330973A (en) 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
CA2093429A1 (en) * 1990-10-09 1992-04-10 Shieh-Shung T. Chen Process for biophosphorylating organic compounds
US5219985A (en) * 1990-10-31 1993-06-15 Merck & Co., Inc. Antifungal agent
US5229363A (en) * 1991-02-19 1993-07-20 Merck & Co., Inc. Cyclic hexapeptide compounds
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5336756A (en) * 1991-05-01 1994-08-09 Merck & Co., Inc. Process for crystalline cyclic lipopeptides
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5348940A (en) * 1991-10-01 1994-09-20 Merck & Co., Inc. Cyclohexapeptidyl hydroxypropionitrile compounds
EP0539088B1 (en) * 1991-10-17 1996-07-17 Merck & Co. Inc. Echinocandin b derivative
US5914313A (en) * 1991-10-17 1999-06-22 Merck & Co., Inc. 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1994025045A1 (en) * 1993-05-04 1994-11-10 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
JP2009514779A (ja) * 2003-07-11 2009-04-09 グラクソ グループ リミテッド 医薬製剤
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
CA1183127A (en) * 1979-12-13 1985-02-26 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
EP0057724A1 (en) * 1980-08-15 1982-08-18 Sandoz Ag New metabolites, processes for their production and their use
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product

Also Published As

Publication number Publication date
CY1962A (en) 1997-07-04
NO178343B (no) 1995-11-27
KR0145693B1 (ko) 1998-08-01
DE69011006T2 (de) 1995-01-26
FI93647C (fi) 1995-05-10
FI93647B (fi) 1995-01-31
AU5797390A (en) 1991-01-03
IL94862A0 (en) 1991-04-15
NO902921D0 (no) 1990-06-29
AU639698B2 (en) 1993-08-05
KR910001068A (ko) 1991-01-30
JPH03163096A (ja) 1991-07-15
PT94555B (pt) 1997-02-28
CA2020062A1 (en) 1990-12-31
FI903280A0 (fi) 1990-06-28
NZ234225A (en) 1993-09-27
PT94555A (pt) 1991-05-22
HK209496A (en) 1996-11-29
EP0405997B1 (en) 1994-07-27
EP0405997A1 (en) 1991-01-02
ES2057413T3 (es) 1994-10-16
IL94862A (en) 1994-10-07
NO178343C (no) 1996-03-06
DE69011006D1 (de) 1994-09-01
ATE109160T1 (de) 1994-08-15
JPH0764873B2 (ja) 1995-07-12
CA2020062C (en) 1997-01-14
DK0405997T3 (da) 1994-10-31

Similar Documents

Publication Publication Date Title
DK0405997T3 (da) Antibiotisk middel
ES2052574T3 (es) Antibioticos glicopeptidos.
ES2082003T3 (es) Deshidrodidemnina b.
ATE157120T1 (de) Biomaterial auf kollagenbasis und seine anwendungen
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
EP0311194A3 (en) Process for antifungal fermentation product and culture
ATE78490T1 (de) Glykopeptid-antibiotika.
ES2061770T3 (es) Antibioticos tan-1057.
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
ES2067520T3 (es) Antibioticos y procedimiento para su produccion.
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
ES2099274T3 (es) Derivados de estreptolisina o.
ATE111487T1 (de) Antibiotisches zyklisches hexapeptid.
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
ATE112169T1 (de) Menschliche myeloperoxidase und therapeutische verwendung.
HU9200385D0 (en) Megacariocitopoietic factor
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
AU6877587A (en) Expellants of phytopathogenic microbes
ES2043993T3 (es) Cultivo de plantas.
SE8400450D0 (sv) Luzopeptin e?712
AR240063A1 (es) Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135.
ES2060957T3 (es) Antibiotico antitumoral bu-3285t.
SU1795646A1 (ru) Комплекс 2-ацетиламино-5-нитротиазола с поливинилпирролидоном, обладающий антимикробной активностью по отношению к неспорообразующей анаэробной инфекции

Legal Events

Date Code Title Description
MK1K Patent expired